Elsight announced the appointment of Mr. Peter Ashley Marks as a Non-Executive Director of the Company effective immediately. Peter brings over 30 years' experience in corporate advisory and investment banking to the Board. Over the course of his esteemed career, he has specialized in capital raising IPOs, cross border M&A transactions, corporate underwriting, and venture capital transactions for companies in Australia, the U.S., and Israel. He has been involved in a very broad range of transactions, with a special focus in the life sciences, biotechnology, medical technology and the high tech segments. Peter brings invaluable experience to the Board of Directors, and his corporate expertise accrued over his long career will be an important asset to the company.